News | April 20, 2026
Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
PMDA is regarded among the most stringent regulatory bodies globally
PMDA is regarded among the most stringent regulatory bodies globally
The innovation is particularly suited for bone and cartilage repair
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Move strengthens footprint in Western India and expands multi-specialty care network
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
The investment case for health technology in India is frequently overstated in one direction and understated in another
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Subscribe To Our Newsletter & Stay Updated
